Most Read Articles
5 days ago
In patients with type 2 diabetes, obesity may be protective against vision-threatening diabetic retinopathy, a recent Korea study has shown.
Roshini Claire Anthony, 4 days ago

Men with metastatic hormone-sensitive prostate cancer (mHSPC) who receive testosterone suppression therapy may have a better survival outcome with the addition of enzalutamide over other non-steroidal anti-androgen (NSAA) therapies, according to the phase III ENZAMET* trial.

07 Jun 2019
Low-dose aspirin therapy does not confer significant benefits to elderly patients with hypertension, but treatment appears to increase the risk of haemorrhagic events, suggest a Japan study.
4 days ago
The use of opioids may have limited long-term efficacy in the management of chronic noncancer pain, reports a new study.

Long-acting opioid tied to increased risk of serious infections

07 Oct 2018

Patients using long-acting opioids with immunosuppressive properties are at greater risk of developing serious infections compared with those using the nonimmunosuppressive opioid counterpart, according to a study.

The study involved Tennessee Medicaid adult enrolees initiating long-acting opioids for pain. Infection risk was compared between individuals using long-acting opioids with known immunosuppressive properties (eg, morphine, fentanyl and methadone; n=61,240) and those using long-acting opioids without immunosuppressive properties (eg, oxycodone, oxymorphone and tramadol; n=22,811).

A total of 1,906 serious infections were identified during 55,663 person-years of follow-up (3.42 hospitalizations for serious infections per 100 person-years). The most common infection was pneumonia (56.1 percent), followed by cellulitis (17.9 percent), bacteraemia without pneumonia (15.3 percent), pyelonephritis (6.1 percent) and septic arthritis/osteomyelitis (3.8 percent).

Multivariate Poisson regression models showed that compared with nonimmunosuppressive opioid users, individuals using immunosuppressive opioids had a lower rate of serious infections (adjusted incidence rate ratio [aIRR], 0.78; 95 percent CI, 0.66–0.91).

Among individual opioids, oxycodone yielded the lowest risk of infection (aIRR, 0.73; 0.61–0.89). No significant differences in the infection risk were observed among other opioids and morphine.

The present data are consistent with results from animal and in-vitro experimental studies showing immunosuppressive properties only in certain opioids, researchers said. It is therefore important to carefully consider the risk of serious infections when making pain management decisions.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
5 days ago
In patients with type 2 diabetes, obesity may be protective against vision-threatening diabetic retinopathy, a recent Korea study has shown.
Roshini Claire Anthony, 4 days ago

Men with metastatic hormone-sensitive prostate cancer (mHSPC) who receive testosterone suppression therapy may have a better survival outcome with the addition of enzalutamide over other non-steroidal anti-androgen (NSAA) therapies, according to the phase III ENZAMET* trial.

07 Jun 2019
Low-dose aspirin therapy does not confer significant benefits to elderly patients with hypertension, but treatment appears to increase the risk of haemorrhagic events, suggest a Japan study.
4 days ago
The use of opioids may have limited long-term efficacy in the management of chronic noncancer pain, reports a new study.